Congratulations Dr Brankin! Philip Fowler, 21st January 202321st January 2023 Alice successfully defended her thesis “Predicting Fluoroquinolone Resistance in Mycobacterium tuberculosis” yesterday. Her examiners were Professor Philip Biggin and Dr Esther Robinson. Much of Alice’s research was done during various SARS-CoV-2 lockdowns and I doubt she thought at the start she’d be using Microsoft Teams so much. Despite this she has produced some excellent research and we wish her all the best at the WHO! Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Related group
New preprint: automatically building a better bedaquiline catalogue 31st January 202531st January 2025 A catalogue recording whether individual mutations confer resistance or not to specified antibiotics is a… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More
group Philip Fowler joins Reuben College as a Fellow 18th September 20238th December 2023 Very pleased to announce that I’ve been elected an Official Fellow at Reuben College. The… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More
antimicrobial resistance New preprint: Predicting antibiotic resistance in complex protein targets 4th January 20224th January 2022 In this preprint, which Alice has been working on for several years, we show how… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More